Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT et al. Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure the better effectiveness after transition-heart failure (BEAT-HF) randomized clinical trial. JAMA 248. Ordonez-Llanos J, Collinson PO, Christenson RH. Amino-terminal pro-B-type natriuretic peptide: analytic considerations. American Journal of Cardiology. 2008; 101(3a):9-15 249. Organisation for Economic Co-operation and Development (OECD). Purchasing power parities (PPP). Available from: http://www.oecd.org/std/prices-ppp/ Last accessed: 06/12/2017. 250. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. New England Journal of Medicine. 1996; 334(21):1349-55 251. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P et al. Effect of carvedilol on survival in severe chronic heart failure. New England Journal of Medicine. 2001; 252. Pandor A, Thokala P, Gomersall T, Baalbaki H, Stevens J, Wang J et al. Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation. Health Technology Assessment. 2013; 253. Panza JA, Holly TA, Asch FM, She L, Pellikka PA, Velazquez EJ et al. Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. Journal of the American College of Cardiology. 2013; 61(18):1860-70 254. Panza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR et al. Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction. Journal of the American College of Cardiology. 2014; 64(6):553-61 255. Paterson I, Wells GA, Ezekowitz JA, White JA, Friedrich MG, Mielniczuk LM et al. 